Vialwirebiotech, curated
November 21, 2026, 6:02 PM
July 2, 2026
- 12:29 PM · Drug Discovery World12:29 PMSyngene appoints Mittal as Managing Director and CEO — Drug Discovery World
- 12:00 PM · BioWorld12:00 PMGenentech’s KRAS G12C inhibitor divarasib shines in NSCLC phase III — BioWorld
- 11:04 AM · BioPharma Dive11:04 AMA PureTech startup banks $180M for a new IPF drug — BioPharma Dive
- 10:19 AM · BioPharma Dive10:19 AMRoche KRAS drug succeeds in head-to-head lung cancer study — BioPharma Dive
- 10:14 AM · Pharmaceutical Technology10:14 AMOutsourcing gap widens: Europe pulls away from US in new drug manufacturing — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMArtan closes seed round to support tRNA platform — BioWorld
- 9:00 AM · BioWorld9:00 AMRibocure and Madrigal nominate siRNA drug candidate for MASH — BioWorld
- 8:54 AM · STAT News
- 7:00 AM · SCMP — Tech7:00 AMChina AI drug-design deals swell as US scrutiny mounts — SCMP — Tech
- 3:23 AM · Pharmaceutical Technology3:23 AMInocras, AimedBio team up for cancer treatments — Pharmaceutical Technology
- 1:00 AM · Bloomberg — Technology1:00 AMNovo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark — Bloomberg — Technology
July 1, 2026
- 11:31 PM · Nikkei Asia11:31 PMTakeda and Insilico strike AI-led drug discovery deal worth up to $600m — Nikkei Asia
- 12:00 PM · BioWorld12:00 PM‘Cool move’ by Zimmer part of med-tech’s tuck-in deals trend — BioWorld
- 12:00 PM · BioWorld12:00 PMIn 2nd deal of week, Ipsen buys Memo’s kidney transplant antibody — BioWorld
- 11:30 AM · Drug Discovery World11:30 AMCHMP adopts positive opinion for severe alopecia treatment — Drug Discovery World
- 10:20 AM · Pharmaceutical Executive10:20 AM<![CDATA[Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge ]]> — Pharmaceutical Executive
- 10:00 AM · Pharmaceutical Executive10:00 AM<![CDATA[AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS]]> — Pharmaceutical Executive
- 9:59 AM · Drug Discovery World9:59 AMAWS supports Fleming Initiative in boost to AMR treatment — Drug Discovery World
- 9:57 AM · Pharmaceutical Technology9:57 AMSanofi aims for Nexviazyme approval in younger Pompe disease patients — Pharmaceutical Technology
- 9:18 AM · BioPharma Dive9:18 AMAbivax shares surge as worries subside over immune drug’s cancer risk — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMMED-EL acquires gene therapy programs from Rescue Hearing — BioWorld
- 9:00 AM · BioWorld9:00 AMFlare Therapeutics to focus on AR-ON degrader FX-111 — BioWorld
- 9:00 AM · BioWorld9:00 AMGrant supports Aptevo’s immunotherapy APVO-451 for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMTelum Therapeutics advances antimicrobials with series A funding — BioWorld
- 8:50 AM · Pharmaceutical Technology8:50 AMEAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s — Pharmaceutical Technology
- 7:38 AM · STAT News7:38 AMSTAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients — STAT News
- 6:00 AM · SCMP — Tech6:00 AMHow a ‘Chinese heart’ could get US blood pumping despite biotech decoupling — SCMP — Tech
- 5:53 AM · Pharmaceutical Technology5:53 AMUS FDA rejects approval of Unicycive’s kidney disease therapy — Pharmaceutical Technology
- 5:09 AM · Pharmaceutical Technology5:09 AMEAN 2026: following EU approval, AbbVie highlights Aquipta efficacy for acute migraine — Pharmaceutical Technology
- 3:32 AM · Pharmaceutical Technology3:32 AMEli Lilly and Innovent agree Verzenios commercialisation deal in China — Pharmaceutical Technology